Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 3913 - 3920 of 11616 results
What is AB 5?
April 6, 2020| Video| Viewpoint
Best Practices for AB 5 Compliance
April 6, 2020| Video| Viewpoint
A Review of the Affordable Care Act at 10 Years
April 6, 2020| Blog| Viewpoint
The CARES Act: What Multifamily Owners with Federally Backed Mortgage Loans Should Know
April 6, 2020| Blog| Viewpoint
Pharmacists Get Licensing Leeway to Help Fight Virus Pandemic
April 6, 2020| News
SEC Says No Reg. BI Extension Despite COVID-19 Concerns
April 6, 2020| Blog| Viewpoint
COVID-19 and GDPR Obligations for Companies
April 6, 2020| News
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.